Anti-aging healthcare
WHY Cellpia
Stem cell anti-aging healthcare
Professor David A. Sinclair of Harvard Medical School, the world's leading scientist on aging and genetics states that it is not aging-related diseases, but aging itself as a disease that needs to be treated. Modern medical research is focusing on 'aging', the root of all major diseases. In the 100-year-old life era, stem cells are the answer to living a long and healthy life!
Healthy blood vessels, healthy whole body!
Blood vessels are important passageways that spread throughout the body to provide nutrients and oxygen to every corner of our body. Clean and healthy blood vessels can ensure easy cell movement and enough nutrients and oxygen delivery.
-
01
When blood vessels are clogged or getting narrow and harden with blood clots form due to cholesterol, etc., they impede the smooth movement of cells, which can cause high blood pressure, blood circulation disorders, arteriosclerosis, and heart failure.
-
02
When stem cells are administered, the stem cells transplanted into blood vessels travel through our body, focusing more on where regeneration is needed and creating new blood vessels where there is an insufficient blood supply to help ensure a smooth supply of oxygen and nutrients.
Immunity-strengthening and anti-aging health care effect of stem cell
Cellpia stem cells reduce fatigue, increase vitality, and increase immunity. Regular management every 3 to 6 months will enhance the effect.
-
Enhance intestinal function
Enhance liver function
Enhance lung function
Aging slowdown, anti-aging
Relieve chronic fatigue
Increase immunity
Reinforce regenerative ability
Improve sexual function
StemCell Health Care
Stem cell anti-aging injection
Clean and healthy blood vessels can ensure easy cell movement and enough nutrients and oxygen delivery. Because vascular disease symptoms appear after more than 70% of progress in the deterioration, it is important to manage it at an early stage.
Blood vessel's inner wall treatment effect
Treatment technology is registered as a new medical technology
Autologous bone marrow stem cell therapy in patients with myocardial infarction, Ministry of Health and Welfare Notice No. 2013-178 (Miracell)
